Request Demo
Last update 08 May 2025
Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)
Last update 08 May 2025
Overview
Basic Info
Drug Type Prophylactic vaccine |
Synonyms 重组乙型肝炎疫苗（汉逊酵母，CpG和铝佐剂）(远大赛威信) + [4] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)CTR20243962
随机、双盲、阳性对照设计评价18岁及以上人群，以不同免疫程序接种重组乙型肝炎疫苗（汉逊酵母，CpG和铝佐剂）的免疫原性和安全性的Ⅱ期临床试验
[Translation] A randomized, double-blind, positive-controlled phase II clinical trial to evaluate the immunogenicity and safety of recombinant hepatitis B vaccine (Hansen yeast, CpG and aluminum adjuvant) in people aged 18 years and above with different immunization schedules
CTR20233405
单中心、随机、双盲、对照设计评价重组乙型肝炎疫苗（汉逊酵母，CpG和铝佐剂）以0，1，6月免疫程序在18岁及以上健康人群中接种的安全性和耐受性的Ⅰ期临床试验
[Translation] A phase I clinical trial of a single-center, randomized, double-blind, controlled design to evaluate the safety and tolerability of a recombinant hepatitis B vaccine (Hansen yeast, CpG and aluminum adjuvant) administered at 0, 1, and 6 months in healthy people aged 18 years and above
CTR20230989
单中心、随机、盲法、阳性对照设计评价重组乙型肝炎疫苗（TVAX-009B）以0、1、6月程序接种在16岁及以上人群的安全性和免疫原性的I期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase I clinical trial to evaluate the safety and immunogenicity of a recombinant hepatitis B vaccine (TVAX-009B) administered at 0, 1, and 6 months in people aged 16 years and older
100 Clinical Results associated with Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)
Login to view more data
100 Translational Medicine associated with Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)
Login to view more data
100 Patents (Medical) associated with Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)
Login to view more data
100 Deals associated with Recombinant Hepatitis B Vaccine(Hansenula polymorpha)(Grand Theravac)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B | Phase 2 | China | 31 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free